Australian Private Health Insurance: Market
Structure, Profitability, and Structural Risk

Australian private health insurance is dominated by four organisations whose combined market share has been structurally stable for at least a decade. Medibank Private holds 26.7% of resident policyholders, Bupa Australia holds 25.4%, HCF holds 12.6%, and nib Holdings holds 9.7%, leaving roughly 25% shared among more than 30 smaller registered health funds. [APRA] The top two alone — both investor-owned or operating at commercial scale — account for more than half the market. That concentration gives them material advantage in hospital contracting negotiations and in absorbing regulatory compliance costs.

The most significant competitive development in FY2025 was HCF's membership growth. As a not-for-profit mutual, HCF grew domestic health insurance membership 4.0% to exceed 2 million policyholders, explicitly gaining market share. [HCF AR] Its insurance revenue rose 4.9% to $4,182 million — faster than the industry average — suggesting it is attracting members away from for-profit competitors, likely by returning more surplus to members through lower premiums or richer benefits. The trade-off is margin: HCF's adjusted insurance service result declined by $65.7 million in FY2025 as higher hospital and ancillary benefit costs eroded margins, partially offset by $24.7 million in higher investment income. [HCF AR]

Medibank's model shows a different set of priorities. Health insurance operating profit grew 7.1% to $741.5 million, driven by $10 million in productivity savings and a 14.1% rise in net investment income to $207.8 million. [Medibank AR] Medibank is also the only major fund with a significant adjacent health services business — the Medibank Health segment grew operating profit 27.0% to $76.7 million in FY2025 — creating a vertically integrated revenue stream that pure insurers cannot replicate. The strategic gap between Medibank's integrated model and the rest of the market is widening, not narrowing.

Medibank Private's FY2025 results are the clearest window into where profitability is coming from. Health insurance operating profit reached $741.5 million, up 7.1% on the prior year. Group revenue from external customers rose 5.2% to $8,604 million. Net profit attributable to shareholders grew just 1.7% to $500.8 million — a narrower gain than operating profit growth, indicating that below-the-line costs and taxes absorbed much of the improvement. [Medibank AR]

The composition of that profit is the more important number. Net investment income rose 14.1% to $207.8 million in FY2025. APRA's sector-wide data indicates that investment income drove approximately 75% of industry profits across all registered health funds in FY2025, with the proportion skewing even higher for smaller funds. [APRA] This matters for investors because it means the current profit cycle is partly a function of the higher interest rate environment that has prevailed since 2022 — not purely a sign that insurers are managing claims costs better. If the Reserve Bank of Australia cuts rates aggressively through 2026 and 2027, the investment income contribution will shrink, and underwriting margins — which face structural claims pressure — will need to compensate.

HCF presents the counter-example. As a not-for-profit, HCF's adjusted insurance service result declined $65.7 million in FY2025, reflecting higher hospital and ancillary benefit costs that the fund chose not to fully pass on to members. [HCF AR] HCF's capital adequacy multiple of 2.51 times the APRA minimum remains solid, providing a buffer, but the margin erosion demonstrates what happens when a fund prioritises membership growth over underwriting returns. The for-profit model — Medibank's approach — protects short-term margins; the mutual model trades margin for membership. Neither approach has found a way to make the underlying claims cost trajectory sustainable without further premium increases.

The Australian PHI value chain runs from the government (which sets the regulatory and rebate framework), through fund operators (which collect premiums and control benefit payments), to private hospitals and ancillary providers (which deliver the services members claim against). Margin concentrates heavily at the fund operator layer. Medibank's $741.5 million health insurance operating profit in FY2025 contrasts sharply with the financial distress visible among private hospital operators. [Medibank AR] Healthscope, one of Australia's two largest private hospital chains, entered receivership — a stark illustration of how funding flows are distributed across the chain. [IBISWorld]

Hospitals face two simultaneous pressures. First, they cannot unilaterally raise the rates they charge insurers — those rates are set through bilateral contracting negotiations where the large funds, given their volume, hold the stronger hand. Second, their underlying cost base is rising because of staff shortages, wage growth, and the ageing patient mix that private hospitals increasingly treat. When insurer-negotiated rates do not keep pace with input cost inflation, hospitals absorb the difference or close services. Industry revenue for private hospitals grew just 0.1% annualised through 2025–26, a figure that implies real revenue contraction when adjusted for healthcare wage inflation. [IBISWorld]

Ancillary providers — dentists, optometrists, physiotherapists — operate in a thinner-margin environment still. Extras cover penetration of 54.6% is high, but benefits are capped per year and often fall well short of actual service costs. [APRA] The practical consequence is that members carry significant out-of-pocket costs for ancillary services even when insured, which undermines the value proposition of extras cover and contributes to the broader affordability narrative that is driving tier downgrades.

The average premium increase approved for April 2026 was 4.41%, the largest single-year rise in nearly a decade. [DoH] That increase follows a decade in which the Australian Government Rebate has declined in real terms, meaning members receive less government help toward a premium that is rising faster than wages or general inflation. The combination — rising premiums, shrinking rebates, and a cost-of-living environment that has made every household expense visible — is producing measurable behavioural change.

The primary response is tier slide. Gold-tier hospital policies, which provide the broadest cover including maternity, cardiac, and psychiatric services, have seen steady membership decline as members shift to Bronze and Silver policies that carry more exclusions but lower premiums. [AMA] As of the most recent analysis, 68% of hospital policies in the market carry exclusions — a figure that represents both insurer product design choices and member demand for cheaper options. [AMA] The structural problem with this trend is that Bronze policies exclude many of the services — maternity care, joint replacements, mental health admissions — that represent high-cost claims. As healthier, younger members shift to Bronze, or exit entirely, the risk pool for Gold and comprehensive Silver policies concentrates toward higher-cost claimants.

HCF's 4.0% membership growth in FY2025 suggests that some funds are benefiting from switcher activity rather than pure market growth. [HCF AR] Members are not leaving the system in large numbers — yet — but they are actively shopping for value and moving toward the lowest-premium option that keeps them inside the MLS threshold. Quarterly hospital claims in the December 2025 quarter reached $5.36 billion, up 2.9% quarter on quarter, confirming that while member behaviour is changing, claims costs are not slowing. [APRA] Rising claims from a pool that is simultaneously downgrading is the economic precondition for a death spiral, even if that spiral has not yet commenced.

Australian PHI faces three structural risks that are qualitatively different from cyclical claims fluctuations. They are structural because they cannot be resolved by adjusting premiums or product design — they require either government policy intervention or a fundamental change in how hospitals and insurers share costs. The risks are present simultaneously, and they interact: a hospital network that shrinks reduces the value of insurance, which accelerates tier slide, which concentrates risk, which raises premiums, which triggers more lapses.

The most immediate risk is hospital contracting. Private hospitals operate on thin margins in the best conditions. When claims reimbursement rates negotiated with large insurers do not keep pace with staff wages and supply costs, hospitals either close elective services or exit private contracts entirely. Healthscope's receivership is the most prominent recent example, but ward closures and service reductions at smaller private hospitals are a broader pattern. [IBISWorld] The fund operators' response — to resist higher reimbursement rates to protect their own margins — is rational at the individual fund level but collectively shrinks the network of services that gives hospital cover its value. [AMA]

Adverse selection operates more slowly but is harder to reverse once established. The Gold-to-Bronze tier slide concentrates high-cost claimants in comprehensive policies, pushing premiums for those tiers higher, prompting further exits by members who believe the premium is no longer worth the cover. APRA monitors this through membership statistics, and the early-warning indicators are already visible: rising exclusion rates, declining Gold-tier penetration, and the 4.41% April 2026 average increase that signals funds are already pricing for a worsening risk pool. [APRA] [DoH] Policy risk — a future government softening the MLS threshold or rebate structure — is the least likely near-term risk but would have immediate and large impact on market participation.

APRA supervises registered health funds under the Private Health Insurance (Prudential Supervision) Act 2015, requiring funds to maintain capital adequacy above a statutory minimum. Medibank reported a capital adequacy ratio of 14.0% against a 10–12% target, and HCF maintained a capital adequacy multiple of 2.51 times the APRA minimum — both well above the regulatory floor. [Medibank AR] [HCF AR] APRA's prudential framework is not the binding constraint on this market's dynamics — it is the demand-side architecture that matters far more.

The government's three-pillar structure — the Australian Government Rebate, the Medicare Levy Surcharge, and Lifetime Health Cover loading — functions as an engineered demand mechanism. The MLS threshold for 2025–26 is set at $101,000 for singles and $202,000 for families. [DoH] These thresholds have been indexed over time but not at a pace that maintains constant incentive intensity across the income distribution. As income growth has lifted more households above the threshold while the real cost of premiums has also risen, the net financial calculus of holding hospital cover has deteriorated for some income brackets.

The Department of Health's annual premium approval process is the most immediate regulatory lever. The 4.41% April 2026 average approval is higher than in any year since the mid-2010s, signalling that the government accepted fund arguments that claims cost inflation left no alternative. [DoH] The political sensitivity of premium increases — they are announced publicly and attract media coverage — means the government faces competing pressures: approve increases large enough to keep funds solvent, but not so large as to accelerate membership decline or generate electoral backlash.

The bull case for Australian PHI rests on two conditions neither of which is currently in place: a government reform of the rebate structure to restore real value, and a resolution of the hospital contracting dynamic that makes private hospital economics viable without continuous government subsidy. Without both, the structural forces identified in this report — tier slide, hospital network contraction, investment income dependency — will continue to erode the underlying quality of earnings even as headline profits hold up in the near term. [AMA]

The base case — assigned 50% probability — is continued premium inflation at or above current rates (4–5% annually), continued tier slide, and episodic hospital contracting crises that generate political pressure but not structural reform. Under this scenario, the large funds (Medibank, Bupa) protect margins through scale and vertical integration, smaller funds consolidate or exit, and overall hospital cover penetration drifts below 44% by 2028. Investment income provides a profit buffer while the underwriting business deteriorates slowly. [IBISWorld]

The bear case is not a black swan — it is the trajectory the market is already on if hospital closures accelerate. If two or three major private hospital operators reduce services or exit contracts in 2026–27, the value proposition of hospital cover becomes directly observable to members: they are paying more for cover that accesses a shrinking network. The resulting acceleration in Gold-tier lapses would push premiums sharply higher, validating member concerns and triggering the adverse selection dynamic in earnest. APRA's early-warning signals — declining membership statistics, rising lapse rates, increasing benefits-to-premiums ratios — are the indicators to watch through Q3 and Q4 2026. [APRA]